Used in research as a potent inhibitor of cyclin-dependent kinases (CDKs), particularly CDK2 and CDK4, making it valuable in studies related to cell cycle regulation and cancer development. Shows promise in preclinical models for antitumor activity due to its ability to induce cell cycle arrest and apoptosis in cancer cells. Also employed as a molecular probe to investigate signaling pathways involved in proliferation and transcription. Its selective kinase inhibition profile supports its use in developing targeted cancer therapies.